Beta Bionics (BBNX) Accumulated Expenses (2023 - 2026)

Beta Bionics' Accumulated Expenses history runs 4 years deep, the most recent figure standing at $17.3 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 64.02% year-over-year to $17.3 million; the TTM figure through Mar 2026 stood at $17.3 million (up 64.02% YoY), while the FY2025 annual figure was $22.4 million, up 41.72% from the prior year.
• Accumulated Expenses came in at $17.3 million for Q1 2026 at Beta Bionics, down from $22.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $22.4 million in Q4 2025 to a low of $8.1 million in Q4 2023.
• A 4-year average of $15.0 million and a median of $15.8 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses soared 94.73% in 2024 and soared 41.72% in 2025, its largest moves.
• Beta Bionics' Accumulated Expenses stood at $8.1 million in 2023, then jumped by 94.73% to $15.8 million in 2024, then soared by 41.72% to $22.4 million in 2025, then declined by 22.75% to $17.3 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $17.3 million, $22.4 million, and $17.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison